Floatz logo

Therapeutic Asset Ratings

5,108 results matching 1 filter

91,564 assets · 7,904 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Xaliplatin
Hepatoblastoma
Children's Oncology GroupP3BB (66)
Xaliplatin
Pediatric Hepatocellular Carcinoma
Children's Oncology GroupP3BB (66)
Xaliplatin
Esophageal Squamous Cell Carcinoma
Taiho Oncology, Inc.P3BB (66)
Xaliplatin
Gastric Cancer
Qilu Pharmaceutical Co., Ltd.P3BB (66)
Xaliplatin
Liver Cancer
Sun Yat-sen UniversityP3BB (66)
Xaliplatin
Neuroendocrine Neoplasm
ITM Solucin GmbHP3BB (66)
Xaliplatin
Ovarian Carcinoma
Moscow Regional Oncological DispensaryP3BB (66)
Xaliplatin
Ovarian Mucinous Cystadenocarcinoma
National Cancer Institute (NCI)P3BB (66)
Xcopri
Focal Epilepsy
SK Life Science, Inc.P3BB (66)
xnw5004
Peripheral T-Cell Lymphoma, Not Otherwise Specified
Evopoint Biosciences Inc.P3BB (66)
Zanubrutinib
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
M.D. Anderson Cancer CenterP3BB (66)
Zanzalintinib
Pancreatic Neuroendocrine Tumor
ExelixisP3BB (66)
Abiraterone
Hypogonadism
SWOG Cancer Research NetworkP3BB (65)
Acalabrutinib
Diffuse Large B-Cell Lymphoma
Ruijin HospitalP3BB (65)
Adriamycin
Urinary Bladder Carcinoma
Toray Industries, IncP3BB (65)
Adriamycin
Endometrial Cancer
Yonsei UniversityP3BB (65)
Adriamycin
Lymphoplasmacytic Lymphoma
National Cancer Institute (NCI)P3BB (65)
Adriamycin
Marginal Zone Lymphoma
Henan Cancer HospitalP3BB (65)
Adriamycin
Metastatic Malignant Neoplasm
City of Hope Medical CenterP3BB (65)
Adriamycin
Peritoneum Cancer
Brigham and Women's HospitalP3BB (65)
Adriamycin
Relapsed/Refractory Diffuse Large B-Cell Lymphoma
City of Hope Medical CenterP3BB (65)
Adriamycin
T-Cell Acute Lymphoblastic Leukemia
SWOG Cancer Research NetworkP3BB (65)
Adriamycin
T-Lymphoblastic Lymphoma
Children's Oncology GroupP3BB (65)
al8326
Small Cell Lung Carcinoma
Advenchen Laboratories Nanjing Ltd.P3BB (65)
Ambroxol
Parkinson Disease
University College, LondonP3BB (65)
Showing 1401 to 1425 of 5,108 assets
PreviousPage 57 of 205Next